Insulinotropic hormone GLP-1 (7-36) and uses thereof

Details Insulinotropic hormone GLP-1 (7-36) and uses thereof Insulinotropic hormone GLP-1 (7-36) and uses thereof

1993-11-23

1997-03-25

Woodward, Michael P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514866, 530303, 530324, 530308, A61K 3826, C07K 14605, C07K 1462

Patent

active

056144920

ABSTRACT:
Derivatives of glucagon-like peptide I (GLP-1) and especially GLP-1(7-36) have been found to have insulinotropic activity. The invention pertains to the use of GLP-1(7-36) for the treatment of type II diabetes mellitus.

REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
Creutzfeldt et al., Diabetes, Larkins et al., (Eds), Elsevier Science Publishers B.V. (Biomedical Division) pp. 193-203 (1989).
Linger et al., Glucagon II, Lefebvre (Ed.,) Springer-Verlag, Berlin, pp. 431-450 (1983).
Gerfel et al., Endocrinology, vol. 126, No. 4, pp. 2164-2168 (1990).
Orskov et al., Diabetes, vol. 42, pp. 658-661 (1993).
Harrison's Principles of Internal Medicine, 11th Edition, Braunwald et al. (Ed.), McGraw-Hill Book Company, p. 1782 (1987).
C. Patzelt et al., Proc. Natl. Acad. Sci., USA, 81:5007-11 (1984).
Schwartz, FEBS Letters, 200(1):1-10 (May 1986).
Drucker et al., J. Biol. Chem., 261(21):9637-43 (1986).
Schmidt, et al., Diabetologia, 28:704-707 (1985).
Garcia, et al., J. Clin. Invest., 57:230-243 (1976).
Tanese, et al., J. Clin. Invest., 49:1394-1404 (1970).
Grodsky, et al., Federation Proc., 36(13):2714-2719 (1977).
Schatz, et al., FEBS Letters, 26(1):237-240 (1972).
Fehmann, et al., Endocrinology, 130(1):159-166 (1992).
Wang, et al., FEBS Letters, 276(1,2):185-188 (1990).
Dobbs, et al., Science, 187:544-547 (1975).
Korman, et al., Diabetes, 34:717-722 (1985).
Mosjov, et al., J. Biol. Chem., 261(25):11880-11889 (1986).
Mosjov, et al., J. Biol. Chem., 265(14):8001-8008 (1990).
Morris, et al., Biochimica et Biophysica Acta, 208:404-413 (1970).
Fehmann, et al., FEBS Letters, 279(2):335-340 (1991).
Hausdorff, et al., FASEB J., 4:2881-2889 (1990).
Orskov, et al., J. Clin. Invest., 87:415-423 (1991).
Nielsen, et al., J. Biol. Chem., 260(25):13585-13589 (1985).
Welsh, et al., J. Biol. Chem., 260(25):13590-13594 (1985).
Hammonds, et al., FEBS Letters, 213(1):149-154 (1987).
Hammonds, et al., FEBS Letters, 223(1):131-137 (1987).
Philippe, et al., J. Biol. Chem., 265(3):1465-1469 (1990).
German, et al., J. Biol. Chem., 265(36):22063-22066 (1990).
Schafer, et al., Acta Endocrinologica, 91:493-500 (1979).
Dobs, et al., In Vitro Cell. Dev. Biol., 25(2):112-114 (1989).
Lee, et al., EMBO J., 9(13):4455-4465 (1990).
Habener, Mol. Endo., 4(8):1087-1094 (1990).
Habener, et al., Molecular Mechanisms in Secretion, Alfred Benzon Symposium 25:476-489 (1988).
Mojsov, et al., J. Clin. Invest., 79:616-619 (1987).
Kreymann, et al., Lancet, pp. 1300-1304, Dec. 5, 1987.
Jones, et al., Diabetologia, 30:707-712 (1987).
George, et al., FEBS Letters, 192(2):275-278 (1985).
Patzelt, et al., Nature, 282:260-266 (1979).
Shields, et al., Nature, 289:511-513 (1981).
Bell, et al., Nature, 302:716-718 (1983).
Andrews, et al., J. Biol. Chem., 260(7):3910-3914 (1985).
Uttenthal, et al., J. Clin. Endocrinol. Metabol., 61(1):472-479 (1985).
Weir, et al., Diabetes, 38(3):338-342 (1989).
Gefel, et al., Endocrinology, 126(4):2164-2168 (1990).
.O slashed.rskov, et al., Endocrinology, 119(4):1467-1475 (1986).
Sarson, et al., Diabetologia, 22:33-36 (1982).
Levy, et al., Biochemical Pharmacology, 24:235-239 (1975).
Lund, et al., Proc. Natl. Acad. Sci. USA, 79:345-349 (1982).
Yanaihara, et al., FEBS Letters, 287(2):307-310 (1985).
Drucker, et al., Proc. Natl. Acad. Sci. USA, 84:3434-3438 (1987).
Ganong, Review of Medical Physiology, Lange Medical Publications, Los Altos, California, pp. 257-276 (1979).
Ghiglione, et al., Diabetologia, 27:599-600 (1984).
Ghiglione, et al., Regulatory Peptides, 13:101 (1985).
Hauner, et al., Ann. Nutr. Metab., 32:282-288 (1988).
Heinrich, et al., Endocrinology, 115(6):2176-2181 (1984).
Holst, et al., FEBS Letters, 211(2):169-174 (1987).
Hoosein, et al., FEBS Letters, 178(1):83-86 (1984).
Houghten, et al., BioTechniques, 4(6):522-528 (1986).
Lopez, et al., Proc. Natl. Acad. Sci. USA, 80:5485-5489 (1983).
Moody, et al., Nature, 289:514-516 (1981).
Meienhofer, Peptides 1984, "Proceedings of the 18th European Peptide Symposium", U. Ragnarsson, (Ed.), Djuronaset, Sweden, pp. 19-34 (1984).
Blackmore, et al., FEBS Letters, 283(1):7-10 (1991).
Rudinger, et al., Peptide Hormones, Parsons (Ed.), U. Park Press, Baltimore, pp. 1-7 (1976).
R. Komatsu et al., Biomedical Research, 9, Supp. 3:201-206 (1988).
NIH Crisp Printout of Abstract for AM30834-01, Fiscal Year 1982, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for AM30834-02, Fiscal Year 1983, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for AM30834-03, Fiscal Year 1984, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for AM30834-04, Fiscal Year 1985, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for DK30834-05, Fiscal Year 1986, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for DK30834-05S1, Fiscal Year 1987, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for DK30834-06A1, Fiscal Year 1988, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Absract for DK30834-07, Fiscal Year 1989, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for DK30834-08, Fiscal Year 1990, "Glucagon biosynthesis and metabolism (fish, rats)".
NIH Crisp Printout of Abstract for DK30834-09, Fiscal Year 1991, "Glucagon biosynthesis and metabolism (fish, rats)".

Affiliated with

Also associated with

Rating

Insulinotropic hormone GLP-1 (7-36) and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulinotropic hormone GLP-1 (7-36) and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulinotropic hormone GLP-1 (7-36) and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2203416